Glaukos To Rally Around 17%? Here Are 6 Top Analyst Forecasts For Tuesday
Glaukos To Rally Around 17%? Here Are 6 Top Analyst Forecasts For Tuesday
Glaukos 是否將上漲約17%?這裏是星期二的6個頂級分析師預測
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
頂級華爾街分析師改變了他們對這些頂級股票的看法。有關所有分析師評級變動的完整信息,包括評級上調和下調,請查看我們的分析師評級頁面。
- Citigroup cut the price target for Valley National Bancorp (NASDAQ:VLY) from $10.5 to $10. Citigroup analyst Ben Gerlinger maintained a Neutral rating. Valley National Bancorp shares closed at $9.12 on Monday. See how other analysts view this stock.
- Wells Fargo cut Sangamo Therapeutics, Inc. (NASDAQ:SGMO) price target from $3 to $2. Wells Fargo analyst Jim Birchenough maintained an Equal-Weight rating. Sangamo Therapeutics shares closed at $2.34 on Monday. See how other analysts view this stock.
- Citigroup raised the price target for Pinnacle Financial Partners, Inc. (NASDAQ:PNFP) from $123 to $132. Citigroup analyst Ben Gerlinger maintained a Buy rating. Pinnacle Financial Partners shares closed at $113.75 on Monday. See how other analysts view this stock.
- HC Wainwright & Co. raised the price target for Arqit Quantum Inc. (NASDAQ:ARQQ) from $27 to $52. HC Wainwright & Co. analyst Scott Buck maintained a Buy rating. Arqit Quantum shares closed at $43.32 on Monday. See how other analysts view this stock.
- Stifel cut Canoo Inc. (NASDAQ:GOEV) price target from $4.5 to $0.5. Stifel analyst Stephen Gengaro downgraded the stock from Buy to Hold. Canoo shares settled at $1.37 on Monday. See how other analysts view this stock.
- Stifel increased Glaukos Corporation (NYSE:GKOS) price target from $153 to $175. Stifel analyst Thomas Stephan maintained a Buy rating. Glaukos shares closed at $149.51 on Friday. See how other analysts view this stock.
- 花旗集團將Valley National Bancorp(納斯達克:VLY)的目標價從10.5美元下調至10美元。花旗集團分析師Ben Gerlinger維持了中立評級。Valley National Bancorp的股票在週一收盤於9.12美元。看看其他分析師對這隻股票的看法。
- 富國銀行將Sangamo Therapeutics, Inc.(納斯達克:SGMO)的目標價從3美元下調至2美元。富國銀行分析師Jim Birchenough維持了與大市相當的評級。Sangamo Therapeutics的股票在週一收盤於2.34美元。看看其他分析師對這隻股票的看法。
- 花旗集團將Pinnacle Financial Partners, Inc.(納斯達克:PNFP)的目標價從123美元上調至132美元。花旗集團分析師Ben Gerlinger維持了買入評級。Pinnacle Financial Partners的股票在週一收盤於113.75美元。看看其他分析師對這隻股票的看法。
- HC Wainwright & Co.將Arqit Quantum Inc.(納斯達克:ARQQ)的目標價從27美元上調至52美元。HC Wainwright & Co.分析師Scott Buck維持了買入評級。Arqit Quantum的股票在週一收盤於43.32美元。看看其他分析師對這隻股票的看法。
- Stifel將Canoo Inc.(納斯達克:GOEV)的目標價從4.5美元下調至0.5美元。Stifel分析師Stephen Gengaro將該股票評級從買入下調至持有。Canoo的股票在週一收盤於1.37美元。看看其他分析師對這隻股票的看法。
- Stifel將Glaukos Corporation(紐交所:GKOS)的目標價從153美元上調至175美元。Stifel分析師Thomas Stephan維持了買入評級。Glaukos的股票在週五收盤於149.51美元。看看其他分析師對這隻股票的看法。
Read This Next:
接下來請閱讀:
- Top 3 Tech Stocks That May Fall Off A Cliff This Quarter
- 本季度可能跌落懸崖的三大科技股票